Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dietary supplement labeling with "internal inconsistency" is "red flag" -- FDA's Yetley.

This article was originally published in The Tan Sheet

Executive Summary

DIETARY SUPPLEMENT LABELS WITH "INTERNAL INCONSISTENCY" WOULD BE A "RED FLAG" attracting FDA's notice, Office of Special Nutritionals Director Elizabeth Yetley, PhD, said at a National Nutritional Foods Association symposium on structure/function claims in Washington, D.C. on Feb. 29. If a product has "a warning that says it's not a drug treatment and a name that implies that it is, then you have an internal inconsistency," Yetley explained.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel